| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98cd39ab42d0194403df1bf07eb36bd5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-2044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate |
2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4daa1f97052ec733dd503671dc261499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ad02e4e920b83836d487e84418c141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d54ab5b410ad5aefd75c70f3056e75d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6151dd9d7be18354e03b5da507888f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b023823f3f754d3a4be0730b14f270ff |
| publicationDate |
2019-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190111828-A |
| titleOfInvention |
Pharmaceutical and functional food composition comprising phosvitin and lysozyme for enhancing immunity |
| abstract |
The present invention relates to a pharmaceutical composition for immuno-enhancing, health functional foods to macrophage activation composition comprising phosvitin and lysozyme. The composition of the present invention has no cytotoxicity against macrophages, and stimulates macrophage activity through the NF-κB, Akt or MAPKs pathways to stimulate nitric oxide (NO) and pro-inflammatory cytokines of macrophages. May increase production and increase phagocytic activity. In particular, the composition comprising phosvitin and lysozyme can significantly increase the production of nitric oxide (NO) of macrophages and is effective as a composition for immuno-enhancing to composition for macrophage activation. |
| priorityDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |